C. Krause

发表

Concurrent inhibition of TGF-β and mitogen driven signaling cascades in Dupuytren's disease - non-surgical treatment strategies from a signaling point of view.

P. Kloen, C. Krause, 2012, Medical hypotheses.

Elevated transforming growth factor β and mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren's disease fibroblasts

P. Kloen, P. ten Dijke, C. Krause, 2011, Fibrogenesis & tissue repair.

Control of bone mass by sclerostin: Inhibiting BMP- and WNT-induced bone formation

P. Dijke, C. Löwik, D. J. J. Gorter, 2008 .

The Imperative Balance of Agonist and Antagonist for BMP Signalling Driven Adult Tissue Homeostasis

C. Krause, 2014 .

Chapter 2: Signal transduction cascades controlling osteoblast differentiation

P. Dijke, David J J de Gorter, P. ten Dijke, 2009 .

Identification of a Key Residue Mediating Bone Morphogenetic Protein (BMP)-6 Resistance to Noggin Inhibition Allows for Engineered BMPs with Superior Agonist Activity*

S. Vukicevic, M. Alaoui-Ismaili, P. ten Dijke, 2010, The Journal of Biological Chemistry.

Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling.

David J J de Gorter, P. ten Dijke, C. Löwik, 2008, The Journal of bone and joint surgery. American volume.

Comprehensive analysis of TGF-β and BMP receptor interactomes.

P. Knaus, C. Krause, A. Guzman, 2012, European journal of cell biology.

Distinct Modes of Inhibition by Sclerostin on Bone Morphogenetic Protein and Wnt Signaling Pathways*

T. Mueller, A. Economides, David J J de Gorter, 2010, The Journal of Biological Chemistry.

Action-based analysis of discrete regulatory networks with short-term stimuli

Erik P. de Vink, Christian Krause, Carola Krause, 2010, CMSB '10.

RGK Small GTP-binding Proteins Interact with the Nucleotide Kinase Domain of Ca2+-channel β-Subunits via an Uncommon Effector Binding Domain*

W. Hunziker, R. Mahalakshmi, Mei Yong Ng, 2007, Journal of Biological Chemistry.